Bioplastics are gaining interest as an alternative to fossil-based plastics. In addition, biodegradable bioplastics may yield biogas after their use, giving an additional benefit. However, the biodegradability time in international norms (35 days) far exceeds processing times in anaerobic digestion facilities (21 days). As the bioplastic packaging does not indicate the actual biodegradability, it is important to understand the time required to biodegrade bioplastic if it ends up in the anaerobic digestion facility along with other organic waste. For this work, cellulose bioplastic film and polylactic acid (PLA) coffee capsules were digested anaerobically at 55 ℃ for 21 days and 35 days, which are the retention times for industrial digestors and as set by international norms, respectively. Different sizes of bioplastics were examined for this work. Bioplastic film produced more biogas than bioplastic coffee capsules. The biodegradability of bioplastic was calculated based on theoretical biogas production. With an increase in retention time, biogas production, as well as biodegradability of bioplastic, increased. The biodegradability was less than 50% at the end of 35 days for both bioplastics, suggesting that complete degradation was not achieved, and thus, the bioplastic would not be suitable for use in biogas digesters currently in use.
LINK
Implementation of reliable methodologies allowing Reduction, Refinement, and Replacement (3Rs) of animal testing is a process that takes several decades and is still not complete. Reliable methods are essential for regulatory hazard assessment of chemicals where differences in test protocol can influence the test outcomes and thus affect the confidence in the predictive value of the organisms used as an alternative for mammals. Although test guidelines are common for mammalian studies, they are scarce for non-vertebrate organisms that would allow for the 3Rs of animal testing. Here, we present a set of 30 reporting criteria as the basis for such a guideline for Developmental and Reproductive Toxicology (DART) testing in the nematode Caenorhabditis elegans. Small organisms like C. elegans are upcoming in new approach methodologies for hazard assessment; thus, reliable and robust test protocols are urgently needed. A literature assessment of the fulfilment of the reporting criteria demonstrates that although studies describe methodological details, essential information such as compound purity and lot/batch number or type of container is often not reported. The formulated set of reporting criteria for C. elegans testing can be used by (i) researchers to describe essential experimental details (ii) data scientists that aggregate information to assess data quality and include data in aggregated databases (iii) regulators to assess study data for inclusion in regulatory hazard assessment of chemicals.
DOCUMENT
Currently the advances in the field of 3D printing are causing a revolution in the (bio-)medical field. With applications ranging from patient-specific anatomical models for surgical preparation to prosthetic limbs and even scaffolds for tissue engineering, the possibilities seem endless. Today, the most widely used method is FDM printing. However, there is still a limited range of biodegradable and biocompatible materials available. Moreover, printed implants like for instance cardiovascular stents require higher resolution than is possible to reach with FDM. High resolution is crucial to avoid e.g. bacterial growth and aid to mechanical strength of the implant. For this reason, it would be interesting to consider stereolithography as alternative to FDM for applications in the (bio-) medical field. Stereolithography uses photopolymerizable resins to make high resolution prints. Because the amount of commercially available resins is limited and hardly biocompatible, here we investigate the possibility of using acrylates and vinylesters in an effort to expand the existing arsenal of biocompatible resins. Mechanical properties are tailorable by varying the crosslink density and by varying the spacer length. To facilitate rapid production of high-resolution prints we use masked SLA (mSLA) as an alternative to conventional SLA. mSLA cures an entire layer at a time and therefore uses less time to complete a print than conventional SLA. Additionally, with mSLA it takes the same time to make 10 prints as it would to make only one. Several formulations were prepared and tested for printability and mechanical strength.
MULTIFILE
Microbes like bacteria and fungi can grow on almost everything, including e.g. on a music CD made of aluminum and polycarbonate. How? By producing an optimal mixture of effective enzymes that degrade the material on which the microbes thrive. In this project we want to find and characterize microbes that have the ability to digest one of the most commercially successful but at the same time hard-to-degrade materials: furan-based bio-composite resin. To help the microbes to degrade this recalcitrant material, we first must open up the complex resin structure by using (mild) acidification, grinding, and/or UV light. Thus, with this project we aim to find an effective and sustainable way to safely and effectively dispose and recycle used bio-composite resins. Our findings will help to increase the circularity of bio-composite materials and as such decrease the environmental waste pressure.
It is known that several bacteria in sewage treatment plants can produce attractive quantities of biodegradable polymers within their cell walls (up to 80% of the cell weight). These polymers may consist of polyhydroxyalkanoates (PHA), a bioplastic which exhibits interesting characteristics like excellent biodegradation, low melting point and good environmental footprint. PHA bioplastics or PHBV are still quite expensive because cumbersome downstream processing steps of the PHAcontaining bacteria are needed before PHA can be applied in products. In this proposal, the consortium investigates the possibilities for eliminating these expensive and environmentally intensive purification steps, and as a result contribute to speeding up the up-take of PHA production of residual streams by the market. The objective of the project is to investigate the possibilities of direct extrusion of PHAcontaining bacteria and the application opportunities of the extruded PHA. The consortium of experienced partners (Paques Biomaterials, MAAN Group, Ecoras and CoEBBE) will investigate and test the extrusion of different types of PHA-containing biomass, and analyse the products on composition, appearance and mechanical properties. Moreover, the direct extrusion process will be evaluated and compared with conventional PHA extraction and subsequent extrusion. The expected result will be a proof of principle and provide an operational window for the application of direct extrusion with PHA-containing biomass produced using waste streams, either used as such or in blends with purified PHA. Both the opportunities of the direct extrusion process itself as well as the application opportunities of the extruded PHA will be mapped. If the new process leads to a cheaper, more environmentally friendly produced and applicable PHA, the proof of principle developed by the consortium could be the first step in a larger scale development that could help speeding up the implementation of the technology for PHA production from residual streams in the market.
Treatment of crops with insecticides remains essential because globally more than 75 billion dollars is lost through crop destruction by invasive insects. However it is accompanied by severe disadvantages including i. increasing resistance of the target insects against insecticides and ii. the undesired lethality of beneficial insects such as bees and other pollinator species. The significant reduction of insect species during the last years, at least partly caused by the presently available insecticides has also effects on insect-eating species. Last but not least the presence of residual amount of insecticides in the environment (soil and plants), because of poor (bio)degradation, is another distinct disadvantage. Therefore, the overall aim of this proposal is to design and synthesize peptide based biopesticides. This should lead to Nature inspired green alternatives for insect control because "Peptides" are the small equivalents of "proteins", that are biomolecules, which are universally present in all organisms and subject to their natural biodegradation mechanisms, as well as also chemically degraded in the soil (water, heat, UV, oxygen). Design and synthesis of these environmentally benign compounds will eventually take place in a founded company called "INNOVAPEPLINE". Evaluation of candidate peptide based biopesticides can be carried out in collaboration with a recently founded company (spin-out of the University of Glasgow) called "SOLASTA BIO" (founders professors Shireen Davies, Julian Dow and Rob Liskamp) and/or with other (third) parties such as the University of Wageningen. Upon recent identification of promising candidate compounds ("leads"), chemical optimization studies of leads will take place, followed by evaluation in field trials. In this proposal design, synthesis and chemical optimization of the biological activity of new peptides and development of methods to monitor their biodegradation rate will take place. Thereby expanding the repertoire of peptide based biopesticides. (292 words)
